TrialJournal of acquired immune deficiency syndromes (1999)2013

Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial.

Samir K Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.